Skip to main content
. Author manuscript; available in PMC: 2007 Feb 27.
Published in final edited form as: Pain. 2006 Mar 13;122(3):245–257. doi: 10.1016/j.pain.2006.01.037

Fig. 3.

Fig. 3

ATF3-immuno-reactivity in nuclei of L4/5 DRG cells. (A) Three days following complete sciatic nerve transection, the majority of cells are ATF3-positive. (B) Day 27 post-paclitaxel initiation, virtually no ATF3-positive cells. Micrographs taken at 10× magnification. Scale bar, 100 μm.